1723 related articles for article (PubMed ID: 15205364)
21. Vascular endothelial growth factor receptor-2 and low affinity VEGF binding sites on human glomerular endothelial cells: Biological effects and advanced glycosilation end products modulation.
Pala L; Cresci B; Manuelli C; Maggi E; Yamaguchi YF; Cappugi P; Rotella CM; Giannini S
Microvasc Res; 2005 Nov; 70(3):179-88. PubMed ID: 16271941
[TBL] [Abstract][Full Text] [Related]
22. Control of blood pressure variability in caveolin-1-deficient mice: role of nitric oxide identified in vivo through spectral analysis.
Desjardins F; Lobysheva I; Pelat M; Gallez B; Feron O; Dessy C; Balligand JL
Cardiovasc Res; 2008 Aug; 79(3):527-36. PubMed ID: 18349137
[TBL] [Abstract][Full Text] [Related]
23. Diabetic mouse angiopathy is linked to progressive sympathetic receptor deletion coupled to an enhanced caveolin-1 expression.
Bucci M; Roviezzo F; Brancaleone V; Lin MI; Di Lorenzo A; Cicala C; Pinto A; Sessa WC; Farneti S; Fiorucci S; Cirino G
Arterioscler Thromb Vasc Biol; 2004 Apr; 24(4):721-6. PubMed ID: 14962949
[TBL] [Abstract][Full Text] [Related]
24. Sustained delivery of sphingosine-1-phosphate using poly(lactic-co-glycolic acid)-based microparticles stimulates Akt/ERK-eNOS mediated angiogenesis and vascular maturation restoring blood flow in ischemic limbs of mice.
Qi X; Okamoto Y; Murakawa T; Wang F; Oyama O; Ohkawa R; Yoshioka K; Du W; Sugimoto N; Yatomi Y; Takuwa N; Takuwa Y
Eur J Pharmacol; 2010 May; 634(1-3):121-31. PubMed ID: 20206620
[TBL] [Abstract][Full Text] [Related]
25. Effects of pulsatile shear stress on signaling mechanisms controlling nitric oxide production, endothelial nitric oxide synthase phosphorylation, and expression in ovine fetoplacental artery endothelial cells.
Li Y; Zheng J; Bird IM; Magness RR
Endothelium; 2005; 12(1-2):21-39. PubMed ID: 16036314
[TBL] [Abstract][Full Text] [Related]
26. Impaired angiogenesis after hindlimb ischemia in type 2 diabetes mellitus: differential regulation of vascular endothelial growth factor receptor 1 and soluble vascular endothelial growth factor receptor 1.
Hazarika S; Dokun AO; Li Y; Popel AS; Kontos CD; Annex BH
Circ Res; 2007 Oct; 101(9):948-56. PubMed ID: 17823371
[TBL] [Abstract][Full Text] [Related]
27. A novel function of VEGF receptor-2 (KDR): rapid release of nitric oxide in response to VEGF-A stimulation in endothelial cells.
Kroll J; Waltenberger J
Biochem Biophys Res Commun; 1999 Nov; 265(3):636-9. PubMed ID: 10600473
[TBL] [Abstract][Full Text] [Related]
28. Angiotensin II type 2 receptor inhibits vascular endothelial growth factor-induced migration and in vitro tube formation of human endothelial cells.
Benndorf R; Böger RH; Ergün S; Steenpass A; Wieland T
Circ Res; 2003 Sep; 93(5):438-47. PubMed ID: 12881481
[TBL] [Abstract][Full Text] [Related]
29. Activation of fractalkine/CX3CR1 by vascular endothelial cells induces angiogenesis through VEGF-A/KDR and reverses hindlimb ischaemia.
Ryu J; Lee CW; Hong KH; Shin JA; Lim SH; Park CS; Shim J; Nam KB; Choi KJ; Kim YH; Han KH
Cardiovasc Res; 2008 May; 78(2):333-40. PubMed ID: 18006432
[TBL] [Abstract][Full Text] [Related]
30. Nitric oxide mediates the mitogenic effects of insulin and vascular endothelial growth factor but not of leptin in endothelial cells.
Józkowicz A; Pankiewicz J; Dulak J; Partyka L; Wybrańska I; Huk I; Dembińska-Kieć A
Acta Biochim Pol; 1999; 46(3):703-15. PubMed ID: 10698278
[TBL] [Abstract][Full Text] [Related]
31. Inhibition of the cardiac angiogenic response to exogenous vascular endothelial growth factor.
Voisine P; Bianchi C; Ruel M; Malik T; Rosinberg A; Feng J; Khan TA; Xu SH; Sandmeyer J; Laham RJ; Sellke FW
Surgery; 2004 Aug; 136(2):407-15. PubMed ID: 15300208
[TBL] [Abstract][Full Text] [Related]
32. Molecular mechanism of limbs' postischemic revascularization improved by perindopril in diabetic rats.
Gao L; Yu DM
Chin Med J (Engl); 2008 Nov; 121(21):2129-33. PubMed ID: 19080171
[TBL] [Abstract][Full Text] [Related]
33. A phosphodiesterase-5 inhibitor vardenafil enhances angiogenesis through a protein kinase G-dependent hypoxia-inducible factor-1/vascular endothelial growth factor pathway.
Sahara M; Sata M; Morita T; Nakajima T; Hirata Y; Nagai R
Arterioscler Thromb Vasc Biol; 2010 Jul; 30(7):1315-24. PubMed ID: 20413734
[TBL] [Abstract][Full Text] [Related]
34. Role of G(i/o)-Src kinase-PI3K/Akt pathway and caveolin-1 in β₂-adrenoceptor coupling to endothelial NO synthase in mouse pulmonary artery.
Banquet S; Delannoy E; Agouni A; Dessy C; Lacomme S; Hubert F; Richard V; Muller B; Leblais V
Cell Signal; 2011 Jul; 23(7):1136-43. PubMed ID: 21385608
[TBL] [Abstract][Full Text] [Related]
35. Central role of calcium-dependent tyrosine kinase PYK2 in endothelial nitric oxide synthase-mediated angiogenic response and vascular function.
Matsui A; Okigaki M; Amano K; Adachi Y; Jin D; Takai S; Yamashita T; Kawashima S; Kurihara T; Miyazaki M; Tateishi K; Matsunaga S; Katsume A; Honshou S; Takahashi T; Matoba S; Kusaba T; Tatsumi T; Matsubara H
Circulation; 2007 Aug; 116(9):1041-51. PubMed ID: 17698736
[TBL] [Abstract][Full Text] [Related]
36. Angiopoietin-related growth factor enhances blood flow via activation of the ERK1/2-eNOS-NO pathway in a mouse hind-limb ischemia model.
Urano T; Ito Y; Akao M; Sawa T; Miyata K; Tabata M; Morisada T; Hato T; Yano M; Kadomatsu T; Yasunaga K; Shibata R; Murohara T; Akaike T; Tanihara H; Suda T; Oike Y
Arterioscler Thromb Vasc Biol; 2008 May; 28(5):827-34. PubMed ID: 18258819
[TBL] [Abstract][Full Text] [Related]
37. Aortic eNOS expression and phosphorylation in Apo-E knockout mice: differing effects of rapamycin and simvastatin.
Naoum JJ; Zhang S; Woodside KJ; Song W; Guo Q; Belalcazar LM; Hunter GC
Surgery; 2004 Aug; 136(2):323-8. PubMed ID: 15300198
[TBL] [Abstract][Full Text] [Related]
38. Caveolin-1 interacts and cooperates with the transforming growth factor-beta type I receptor ALK1 in endothelial caveolae.
Santibanez JF; Blanco FJ; Garrido-Martin EM; Sanz-Rodriguez F; del Pozo MA; Bernabeu C
Cardiovasc Res; 2008 Mar; 77(4):791-9. PubMed ID: 18065769
[TBL] [Abstract][Full Text] [Related]
39. Caveolin-1 null mice are viable but show evidence of hyperproliferative and vascular abnormalities.
Razani B; Engelman JA; Wang XB; Schubert W; Zhang XL; Marks CB; Macaluso F; Russell RG; Li M; Pestell RG; Di Vizio D; Hou H; Kneitz B; Lagaud G; Christ GJ; Edelmann W; Lisanti MP
J Biol Chem; 2001 Oct; 276(41):38121-38. PubMed ID: 11457855
[TBL] [Abstract][Full Text] [Related]
40. Dynamic regulation of endothelial nitric oxide synthase: complementary roles of dual acylation and caveolin interactions.
Feron O; Michel JB; Sase K; Michel T
Biochemistry; 1998 Jan; 37(1):193-200. PubMed ID: 9425039
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
